10-Q: SHF Holdings Secures Capital, Cuts Debt Amid Revenue Slump

Sentiment:

Quarterly Report


SHF Holdings, Inc. reported a significant capital raise and debt reduction, improving its balance sheet and Nasdaq compliance, despite a sharp decline in revenue and a shift to net loss for the nine-month period.

Capital raiseThe Company issued 31,052 shares of Series B Convertible Preferred Stock and accompanying Series B Warrants to purchase 1,999,544 shares of Class A Common Stock for aggregate consideration of $24.8 million.Consideration for the Series B issuance included $6.3 million in cash, $10.8 million in debt cancellation, $4.0 million related to the termination of the Forward Purchase Agreement, and $0.7 million from the exchange of Convertible Notes.An Equity Line of Credit (ELOC) agreement was entered into with CREO Investments LLC, allowing the Company to issue and sell up to $150 million of Class A Common Stock, with potential expansion to $500 million upon mutual agreement.As consideration for establishing the ELOC, the Company issued 1,000 shares of Series B Convertible Preferred Stock and a Series B Warrant to purchase 64,369 shares of Class A Common Stock to the investor.
Worse than expectedRevenue for the three months ended September 30, 2025, decreased by 47.3% to $1.83 million from $3.48 million in the prior year.Revenue for the nine months ended September 30, 2025, decreased by 51.5% to $5.61 million from $11.57 million in the prior year.The Company reported a net loss of $1.58 million for the nine months ended September 30, 2025, a significant decline from a net income of $3.35 million in the same period last year.Net cash used in operating activities for the nine months ended September 30, 2025, was $2.35 million, compared to $3.21 million provided by operating activities in the prior year, indicating increased cash burn from operations.

Summary

  • SHF Holdings, Inc. completed a significant capital restructuring, raising $24.8 million through the issuance of Series B Convertible Preferred Stock and Series B Warrants.
  • The capital raise included $6.3 million in cash, the cancellation of $10.8 million in Senior Secured Promissory Notes, the termination of a $4.0 million Forward Purchase Agreement (FPA) liability, and the exchange of $0.7 million in Convertible Notes.
  • The Company's total stockholders' equity improved dramatically from a deficit of $(12.3) million as of December 31, 2024, to a positive $7.0 million as of September 30, 2025.
  • Nasdaq confirmed that the Company regained compliance with the minimum $2.5 million stockholders' equity requirement.
  • Revenue for the three months ended September 30, 2025, decreased by 47.3% to $1.83 million, and for the nine months, it fell by 51.5% to $5.61 million compared to the prior year.
  • The Company reported a net loss of $1.58 million for the nine months ended September 30, 2025, a significant shift from a net income of $3.35 million in the same period of 2024.
  • Operating expenses decreased by 7.7% for the three months and 9.1% for the nine months ended September 30, 2025, reflecting cost-reduction measures.
  • An Equity Line of Credit (ELOC) facility was established with CREO Investments LLC, allowing the Company to sell up to $150 million of Class A Common Stock, with potential expansion to $500 million.
  • Material weaknesses in internal controls over financial reporting, particularly concerning revenue recognition, remain in the process of remediation.
  • The Company continues to face a legal dispute related to the Abaca acquisition, with $3.0 million in contingent merger consideration held by the Denver County District Court.

Sentiment

Score: 7

Explanation: While operating results show significant declines in revenue and a shift to net loss, the successful capital restructuring, substantial debt reduction, and regaining of Nasdaq compliance are critical positive developments for the Company's solvency and liquidity. The establishment of an ELOC provides a future funding mechanism. However, ongoing internal control weaknesses and high customer concentration remain concerns.

Positives

  • Successfully completed a capital restructuring, raising $24.8 million in aggregate consideration, significantly strengthening the balance sheet.
  • Eliminated $10.75 million in Senior Secured Promissory Notes with Partner Colorado Credit Union (PCCU) through an equity exchange.
  • Extinguished a $7.3 million Forward Purchase Agreement (FPA) derivative liability, resulting in a $3.3 million gain on extinguishment of debt.
  • Achieved a positive stockholders' equity of $7.0 million as of September 30, 2025, reversing a $(12.3) million deficit from December 31, 2024.
  • Regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million.
  • Secured a $150 million Equity Line of Credit (ELOC) facility, providing access to future funding.
  • Operating expenses decreased by $0.26 million (7.7%) for the three months and $1.0 million (9.1%) for the nine months ended September 30, 2025, due to cost-reduction measures.
  • Eliminated indemnification obligations to PCCU for loan losses under the Amended PCCU Commercial Alliance Agreement.
  • Active accounts increased by 3.9% for the quarter and 3.1% for the nine months ended September 30, 2025, demonstrating client retention and modest new-account growth.

Negatives

  • Total revenue decreased significantly by 47.3% to $1.83 million for the three months ended September 30, 2025, and by 51.5% to $5.61 million for the nine months compared to the prior year.
  • The Company reported a net loss of $1.58 million for the nine months ended September 30, 2025, a substantial decline from a net income of $3.35 million in the same period of 2024.
  • Operating income shifted to a loss of $(1.22) million for the three months and $(4.18) million for the nine months ended September 30, 2025, compared to positive operating income in the prior year periods.
  • Net cash used in operating activities for the nine months ended September 30, 2025, was $2.35 million, a reversal from $3.21 million provided in the prior year, indicating increased cash burn.
  • Cash and cash equivalents decreased from $2.32 million at December 31, 2024, to $0.86 million at September 30, 2025.
  • Average monthly deposit balances declined by 13.1% year-over-year for the nine months ended September 30, 2025.
  • Average fees per account decreased by 36.0% for the nine months ended September 30, 2025, driven by the loss of higher-performing accounts and broader economic pressures.
  • Identified material weaknesses in internal controls over financial reporting, particularly regarding the completeness and accuracy of activity fee income from PCCU, remain un-remediated.
  • High concentration risk persists, with PCCU accounting for 85.4% of total revenues for the nine months ended September 30, 2025, and holding the majority of the Company's cash deposits.
  • An ongoing legal dispute related to the Abaca acquisition involves $3.0 million in contingent merger consideration held by the court, creating uncertainty.

Risks

  • Substantial reliance on Partner Colorado Credit Union (PCCU) for revenue (85.4% of total revenues for the nine months ended September 30, 2025) and cash deposits, making the Company vulnerable to changes in this relationship.
  • Ongoing material weaknesses in internal controls over financial reporting, particularly regarding the completeness and accuracy of activity fee income, which could lead to financial misstatements.
  • Exposure to litigation risk from the Abaca acquisition dispute, which could result in adverse decisions, significant defense costs, and diversion of management resources.
  • The cannabis industry's evolving and complex regulatory environment could impact CRB operations and the demand for the Company's financial services.
  • Broader economic pressures within the U.S. cannabis industry, including reduced wholesale pricing and constrained operator liquidity, may continue to negatively affect deposit balances and transaction activity.
  • Potential for significant dilution for existing shareholders from future equity issuances, including through the Equity Line of Credit (ELOC) and conversion of Series B Preferred Stock and Warrants.
  • Market volatility impacting the fair value of warrant liabilities, leading to non-cash gains or losses that affect reported financial results.
  • No assurance that the Company will maintain compliance with all Nasdaq listing requirements in the future, despite regaining current compliance.

Future Outlook

Management anticipates continued cost reductions and improved cash generation, with the full impact of operational efficiencies expected to be realized in 2026. Existing cash resources, combined with potential access to the Equity Line of Credit (ELOC), are projected to be sufficient to fund operations for at least 12 months. The Company believes that broader U.S. economic improvements, particularly increased discretionary spending, and potential regulatory easing in the cannabis industry, such as federal rescheduling, could lead to higher account balances and transaction activity over time. The assessment of operating effectiveness for remediated internal controls is expected to be completed in the fourth quarter of 2025. The registration for the Series B Preferred Stock and Series B Warrants is expected to become effective in November 2025. Shareholders have authorized the Board of Directors to effect a reverse stock split at a ratio between 2-for-1 and 12-for-1 at its discretion.

Management Comments

  • Management is using stock-based compensation awards to reduce the cash component of employee compensation and align incentives with the performance of the Company's Class A Common Stock.
  • The Company believes these results demonstrate that its cost-containment initiatives are generating sustainable reductions in ongoing cash expenditures, the full effect of which is expected to become more evident in 2026.
  • The Company expects that, following completion of the legal and auditor transitions, annualized professional service costs will decline compared with maintaining both internal and multiple external service providers.
  • Based on current forecasts, existing cash resources, combined with potential access to the ELOC, are expected to be sufficient to fund operations for at least 12 months beyond the issuance date of these unaudited condensed consolidated financial statements.
  • The current depositor mix remains more diversified, reducing concentration risk and positioning the Company to benefit from any industry recovery.

Industry Context

The Company operates within the specialized financial services sector for Cannabis Related Businesses (CRBs), an industry characterized by limited access to traditional banking and financing due to regulatory complexities. The fintech platform aims to provide compliant banking solutions, mitigating the high cash volumes prevalent in the cannabis market. The industry is currently experiencing broader economic pressures, including reduced wholesale pricing and constrained operator liquidity, which have negatively impacted the Company's average account balances. Future growth is highly dependent on potential improvements in overall U.S. economic conditions and significant regulatory easing, such as federal rescheduling of cannabis, which could stimulate increased discretionary spending and transaction activity within the sector.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer and Chief Financial OfficerNATerrance E. Mendez2025-01-01Hired to oversee technical accounting, financial reporting, and internal controls, bringing extensive SEC-registrant experience.
Senior Vice President of Finance and Controller (Principal Accounting Officer)NADouglas Beck2025-01-01Hired to oversee technical accounting, financial reporting, and internal controls, bringing extensive SEC-registrant experience.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan AmendmentThe 2022 Equity Incentive Plan was amended to automatically increase the total number of authorized shares of Common Stock upon a Dilution Event and on the first trading day of each calendar year, beginning with 2026, up to 15% of outstanding shares (maximum annual increase of 50,000 shares).2025-04-30Increases flexibility for future equity compensation but also introduces potential for further dilution.
Shareholder Approval for Equity IssuancesShareholders approved the issuance of common stock upon conversion of the Series B Convertible Preferred Stock and upon exercise of related Series B Warrants, including participation by certain members of management and the Board of Directors.2025-11-06Ensures compliance with Nasdaq listing rules for related party transactions and facilitates the capital restructuring.
Shareholder Approval for ELOC SharesShareholders approved the issuance of shares of Class A Common Stock to CREO Investments LLC pursuant to the Common Stock Purchase Agreement (ELOC).2025-11-06Enables the Company to draw on the ELOC facility for future capital, subject to terms and conditions.
Reverse Stock Split AuthorizationShareholders authorized the Board of Directors, in its sole discretion, to effect a reverse stock split of the Company's outstanding common stock at any ratio between 2-for-1 and 12-for-1.2025-11-06Provides the Board with a tool to potentially increase share price and maintain Nasdaq listing requirements, but could also lead to a decrease in the number of outstanding shares.
Board Appointment RightsPCCU no longer has contractual rights to appoint members to the Board of Directors, despite holding a significant ownership interest.2024-12-31Reduces PCCU's direct influence on the Company's board composition, potentially enhancing independent governance.

Legal Proceedings

  • The Company filed a declaratory judgment action in the Denver County District Court (Case No. 2024CV33187) against former Abaca shareholders (Daniel Roda, Gregory W. Ellis, and James R. Carroll) concerning a $3.0 million contingent merger consideration payment.
  • The $3.0 million payment was deposited into the court registry on November 21, 2024, and remains held by the court pending resolution of the dispute among former Abaca shareholders.
  • The Defendants filed a counterclaim against the Company alleging breach of contract and related causes of action, and a third-party claim was asserted against a member of the Company's board of directors.
  • On April 18, 2025, the District Court dismissed Gregory W. Ellis as a counter-plaintiff and third-party plaintiff due to lack of standing.
  • No trial date has been set, and the case remains in the pleading stage; management has determined that no accrual for loss is required as of September 30, 2025.

Related Party Transactions

  • Partner Colorado Credit Union (PCCU) is considered a related party, holding approximately 37.1% of the Company's Class A Common Stock as of September 30, 2025.
  • PCCU no longer has contractual rights to appoint members to the Board of Directors.
  • PCCU holds the majority of the Company's cash deposits.
  • Substantially all of the Company's revenue (88.0% for Q3 2025, 85.4% for 9 months 2025) is derived from services provided to PCCU under the Commercial Alliance Agreement (PCCU CAA).
  • Amounts due from PCCU totaled $0.7 million, representing 93.5% of total accounts receivable, as of September 30, 2025.
  • The Amended PCCU CAA, effective December 31, 2024, eliminated the Company's indemnification obligations to PCCU for loan losses.
  • The Amended PCCU CAA replaced the prior fee structure with an asset hosting fee structure, which has resulted in higher total account hosting costs for the Company.
  • The Company's interest income on loans with PCCU is now calculated using a loan yield allocation formula, resulting in approximately 39% of interest income allocated to the Company.
  • PCCU received 13,436 shares of Series B Convertible Preferred Stock and a warrant to purchase 865,200 Class A Common Shares in exchange for canceling the $10.75 million Senior Secured Promissory Note.

Stakeholder Impact

  • Shareholders face significant potential dilution from the issuance of Series B Preferred Stock and Warrants, and future draws on the Equity Line of Credit (ELOC). However, the improved balance sheet and Nasdaq compliance are positive for shareholder value.
  • Employees may experience continued workforce realignments as part of cost-reduction measures, but new executive hires and increased stock-based compensation aim to align incentives.
  • Customers (financial institutions and CRBs) continue to receive compliant banking services, though new fee structures with PCCU may alter service costs.
  • Creditors benefit from the substantial reduction in the Company's debt obligations through the cancellation of the Senior Secured Promissory Note and extinguishment of the FPA liability, improving the Company's credit profile.
  • Regulatory bodies will note the Company's regained Nasdaq compliance and ongoing efforts to remediate internal control weaknesses.

Next Steps

  • Continue to implement cost-reduction measures to improve cash generation, with full effects expected in 2026.
  • Complete the assessment of operating effectiveness for remediated internal controls during the fourth quarter of 2025.
  • Monitor the status of the Abaca legal dispute and potential financial exposure.
  • Await the expected effectiveness of the registration statement for Series B Preferred Stock and Series B Warrants in November 2025.
  • Potentially utilize the Equity Line of Credit (ELOC) for future funding, following shareholder approval and registration effectiveness.
  • The Board of Directors may, at its discretion, effect a reverse stock split at a ratio between 2-for-1 and 12-for-1.

Key Dates

DateDescription
2022-06-16Company and Midtown East Management NL, LLC entered into a Forward Purchase Agreement (FPA).
2022-11-11First Amendment to the Merger Agreement with Rockview Digital Solutions, Inc. (Abaca).
2023-01-25Stockholders approved a reduction in the floor conversion price of outstanding preferred stock from $40.00 to $25.00 per share.
2023-03-29Company and PCCU entered into the Commercial Alliance Agreement (PCCU CAA) and a Senior Secured Promissory Note and Security Agreement.
2023-10-26Second Amendment to the Merger Agreement with Abaca, introducing deferred stock consideration and a third-anniversary consideration payment.
2024-10-05Second annual payment of $3 million related to the Abaca merger was due and subsequently held by the Denver County District Court.
2024-10-17Company filed a declaratory judgment action in Denver County District Court against former Abaca shareholders.
2024-11-21Company deposited $3.0 million payment into the registry of the Denver County District Court for the Abaca legal dispute.
2024-12-19Defendants filed a counterclaim against the Company in the Abaca legal dispute.
2024-12-31Amended PCCU Commercial Alliance Agreement became effective, eliminating indemnification obligations and revising fee structures.
2025-01-01Prospective adoption of ASU 2023-09 (Income Taxes), ASU 2024-02 (Codification Improvements), and ASU 2024-01 (Compensation-Stock Compensation).
2025-01-16Company filed a motion to dismiss all counterclaims in the Abaca legal dispute.
2025-03-14A 1-for-20 reverse stock split of the Company's Common Stock became effective.
2025-04-07Company received a notice from Nasdaq regarding non-compliance with the minimum stockholders' equity requirement.
2025-04-18District Court for Denver dismissed Gregory W. Ellis as a counter-plaintiff in the Abaca legal dispute.
2025-04-30The 2022 Equity Incentive Plan was amended to provide for automatic share increases.
2025-05-22Company submitted a compliance plan to Nasdaq, which was accepted.
2025-08-07Company granted 183,501 performance-based stock option awards to executive officers.
2025-08-27Company issued unsecured Convertible Promissory Notes in the aggregate principal amount of $0.7 million.
2025-09-09Company issued an additional unsecured Convertible Promissory Note in the principal sum of $0.1 million.
2025-09-17Company entered into a Common Stock Purchase Agreement (ELOC Agreement) with CREO Investments LLC for up to $150 million.
2025-09-28The Company was required to satisfy its FPA derivative liability of $7.3 million.
2025-09-30End of the current quarterly reporting period. Company issued 31,052 shares of Series B Convertible Preferred Stock and accompanying Series B Warrants. Company entered into a Debt Cancellation Agreement with PCCU. Company entered into Exchange and Cancellation Agreements to extinguish FPA liability. Convertible Notes were exchanged for Series B Preferred Stock and Warrants. Company and CREO Investments LLC executed Amendment No. 1 to the ELOC Agreement.
2025-10-03Company issued 37,517 unregistered shares of Class A Common Stock to Abaca shareholders for the third-anniversary consideration payment.
2025-10-05Third-anniversary consideration payment of $1.5 million was due under the Abaca merger agreement.
2025-10-08Company received $5.9 million in cash proceeds related to the Series B Convertible Preferred Stock and Series B Warrants issuance.
2025-10-17Company filed registration statements on Form S-1 to register the resale of Series B conversion shares and shares issuable under its equity line of credit.
2025-10-21Company filed registration statements on Form S-1 to register the resale of Series B conversion shares and shares issuable under its equity line of credit.
2025-10-31Aditxt, Inc. (ADTX) redeemed approximately 44 shares of its preferred stock held by the Company for cash proceeds of $0.05 million.
2025-11-06Company's shareholders approved an increase in authorized Class A Common Stock, issuance of common stock upon conversion of Series B Preferred Stock and Warrants, issuance of ELOC shares, and authorization for a reverse stock split.
2025-11-07The registration statement for the equity line of credit became effective.
2025-11-10As of this date, 3,081,076 shares of Class A Common Stock were outstanding. The registration statement on Form S-1 covering shares issuable upon exercise of Abaca Warrants became effective.
2025-11-12Date of filing of this Quarterly Report on Form 10-Q.

Recommendation

hold

While SHF Holdings has made significant strides in strengthening its balance sheet through a substantial capital raise and debt reduction, which is a strong positive for solvency and Nasdaq compliance, the underlying operational performance remains challenging. The Company experienced a sharp decline in revenue and a shift to a net loss for the nine-month period, coupled with continued cash burn from operations. High customer concentration with PCCU and un-remediated material weaknesses in internal controls present ongoing risks. The Equity Line of Credit provides a liquidity buffer but also introduces potential for further dilution. A seasoned investor would likely maintain a 'hold' position, awaiting clear signs of operational turnaround and sustained revenue growth before considering a 'buy' recommendation, while acknowledging the improved financial stability prevents a 'sell'.

Keywords

Cannabis Banking, Fintech, SEC Filing, 10-Q, Financial Services, Capital Raise, Debt Reduction, Nasdaq Compliance, Equity Line of Credit, CRB, Partner Colorado Credit Union, Warrants, Preferred Stock, Internal Controls, Legal Proceedings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.